Abstract
Keywords
Get full access to this article
View all access options for this article.
References
1.
Fein
AJ
. Four reasons why PBMs gain as maximizers overtake copay accumulators . Drug Channels . February 8, 2022 . https://www.drugchannels.net/2022/02/four-reasons-why-pbms-gain-as.html. Accessed May 30, 2025.
2.
Zuckerman
AD
Schneider
MP
Dusetzina
SB
. Health insurer strategies to reduce specialty drug spending—copayment adjustment and alternative funding programs . JAMA Intern Med . 2023 ;183 (7 ):635 -636 . doi:10.1001/jamainternmed.2023.1829
3.Now that Copay Assistance Must Count, Government Must Stop Scheme of Classifying Drugs as “Non-essential Health benefits.” HIV+Hepatitis Policy Institute . January 9, 2024 . Accessed April 30, 2025. https://hivhep.org/press-releases/now-that-copay-assistance-must-count-government-must-stop-scheme-of-classifying-drugs-as-non-essential-health-benefits/
4.AB-874 Health care coverage: out-of-pocket expenses . California Legislative Information . February 14, 2023 . Accessed April 30, 2025. https://leginfo.legislature.ca.gov/faces/billNavClient.xhtml?bill_id=202320240AB874
5.
H.R.830 - HELP Copays Act
. Congress.gov . February 6, 2023 . https://www.congress.gov/bill/118th-congress/house-bill/830. Accessed April 30, 2025.